Abstract
Clinical, preclinical, and pharmacological studies have suggested that decreased enkephalin tone is associated with depression-like symptoms and increase in enkephalin signaling could have a therapeutic value in the treatment of depression. In this study we demonstrate that, surprisingly, animals lacking enkephalin (preproenkephalin, Penk1−/−) showed no depression-related phenotype in the Porsolt forced swimming or tail suspension tests. Moreover, Penk1−/− mice had a lower frequency of depression-related behavior in stress-induced hypoactivity and ultrasonic vocalization models of depression, similar to animals treated with antidepressant drugs, although this effect was specific to the genetic background. In addition, there was no significant difference in the efficacy of antidepressant reference compounds in wild-type and knockout animals. Nialamide and amitriptyline were even slightly more effective in animals with genetic deletion of Penk1, whereas the minimal effective dose of imipramine and fluoxetine was the same in the two genotypes. The dual peptidase inhibitor RB-101 was also effective in Penk1−/− as well as in Penk1−/−/Pdyn−/− animals, although its efficacy was somewhat reduced compared with wild-type animals. This result was also surprising because the antidepressant effects of RB-101 were thought to be due to the elevation of enkephalin levels.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bertrand E, Smadja C, Mauborgne A, Roques BP, Dauge V (1997). Social interaction increases the extracellular levels of [Met]enkephalin in the nucleus accumbens of control but not of chronic mild stressed rats. Neuroscience 80: 17–20.
Bilkei-Gorzo A, Racz I, Michel K, Zimmer A, Klingmuller D, Zimmer A (2004). Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology (Berlin) 176: 343–352.
Brady LS, Herkenham M, Rothman RB, Partilla JS, Konig M, Zimmer AM et al (1999). Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice. Brain Res Mol Brain Res 68: 193–197.
Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH (2002). Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26: 744–755.
Brownstein MJ (1980). Opioid peptides: search for the precursors. Nature 287: 678–679.
Clarke S, Zimmer A, Zimmer AM, Hill RG, Kitchen I (2003). Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience 122: 479–489.
Comings DE, Dietz G, Gade-Andavolu R, Blake H, Muhleman D, Huss M et al (2000). Association of the neutral endopeptidase (MME) gene with anxiety. Psychiatr Genet 10: 91–94.
Curtis D, Sherrington R, Brett P, Holmes DS, Kalsi G, Brynjolfsson J et al. (1993). Genetic linkage analysis of manic depression in Iceland. J R Soc Med 86: 506–510.
de Felipe MC, Jimenez I, Castro A, Fuentes JA (1989). Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. Eur J Pharmacol 159: 175–180.
de Gandarias JM, Irazusta J, Varona A, Gil J, Fernandez D, Casis L (1999). Effect of imipramine on enkephalin-degrading peptidases. Eur Neuropsychopharmacol 9: 493–499.
Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF (2001). Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25: 729–741.
Ducottet C, Belzung C (2005). Correlations between behaviours in the elevated plus-maze and sensitivity to unpredictable subchronic mild stress: evidence from inbred strains of mice. Behav Brain Res 156: 153–162.
Dziedzicka-Wasylewska M, Papp M (1996). Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous Met-enkephalin in the rat dopaminergic mesolimbic system. Pol J Pharmacol 48: 53–56.
Ehrenpreis S (1982). D-phenylalanine and other enkephalinase inhibitors as pharmacological agents: implications for some important therapeutic application. Acupunct Electrother Res 7: 157–172.
Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F et al (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195–200.
Holmes PV (1999). Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats. Neuropeptides 33: 206–211.
Jungkunz G, Nedopil N, Ruther E (1983). Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms. Pharmacopsychiatria 16: 90–92.
Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ et al (1996). Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383: 535–538.
Mayorga AJ, Lucki I (2001). Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology (Berlin) 155: 110–112.
Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F (2005). Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135: 305–313.
Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB et al (2004). Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 9: 1007–1029.
Porsolt RD (2000). Animal models of depression: utility for transgenic research. Rev Neurosci 11: 53–58.
Porsolt RD, Bertin A, Jalfre M (1977). Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327–336.
Primeaux SD, Holmes PV (2000). Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures. Pharmacol Biochem Behav 67: 331–337.
Primeaux SD, Wilson MA, Wilson SP, Guth AN, Lelutiu NB, Holmes PV (2003). Herpes virus-mediated preproenkephalin gene transfer in the ventral striatum mimics behavioral changes produced by olfactory bulbectomy in rats. Brain Res 988: 43–55.
Ripoll N, David DJ, Dailly E, Hascoet M, Bourin M (2003). Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 143: 193–200.
Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85: 367–370.
Tejedor-Real P, Mico JA, Maldonado R, Roques BP, Gibert-Rahola J (1993). Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. Biol Psychiatry 34: 100–107.
Tejedor-Real P, Mico JA, Maldonado R, Roques BP, Gibert-Rahola J (1995). Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 52: 145–152.
Tejedor-Real P, Mico JA, Smadja C, Maldonado R, Roques BP, Gilbert-Rahola J (1998). Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur J Pharmacol 354: 1–7.
Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin) 134: 319–329.
Witmer PD, Doheny KF, Adams MK, Boehm CD, Dizon JS, Goldstein JL et al (2003). The development of a highly informative mouse Simple Sequence Length Polymorphism (SSLP) marker set and construction of a mouse family tree using parsimony analysis. Genome Res 13: 485–491.
Zangen A, Nakash R, Roth-Deri I, Overstreet DH, Yadid G (2002). Impaired release of beta-endorphin in response to serotonin in a rat model of depression. Neuroscience 110: 389–393.
Zimmer A, Valjent E, Konig M, Zimmer AM, Robledo P, Hahn H et al (2001). Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J Neurosci 21: 9499–9505.
Zomkowski AD, Santos AR, Rodrigues AL (2005). Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett 381: 279–283.
Acknowledgements
This work was supported by a grant from the German Ministry for Research and Education (NGFN2). The authors declare that they have no competing financial interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bilkei-Gorzo, A., Michel, K., Noble, F. et al. Preproenkephalin Knockout Mice Show No Depression-Related Phenotype. Neuropsychopharmacol 32, 2330–2337 (2007). https://doi.org/10.1038/sj.npp.1301370
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1301370
